Col13a1-KO 基因敲除小鼠

1. Ohno, Kinji, Ohkawara, Bisei, Shen, Xin-Ming, Selcen, Duygu, Engel, Andrew G. 2023. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. In International journal of molecular sciences, 24, . doi:10.3390/ijms24043730. https://pubmed.ncbi.nlm.nih.gov/36835142/

2. Dusl, Marina, Moreno, Teresa, Munell, Francina, Lochmüller, Hanns, Senderek, Jan. 2019. Congenital myasthenic syndrome caused by novel COL13A1 mutations. In Journal of neurology, 266, 1107-1112. doi:10.1007/s00415-019-09239-7. https://pubmed.ncbi.nlm.nih.gov/30767057/

3. Herzog, Brett H, Baer, John M, Borcherding, Nicholas, Govindan, Ramaswamy, DeNardo, David G. 2023. Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer. In Science translational medicine, 15, eadh8005. doi:10.1126/scitranslmed.adh8005. https://pubmed.ncbi.nlm.nih.gov/37285399/

4. Kumon, Masashi, Fuwa, Masahiro, Shimazaki, Atsushi, Yoneda, Kenji, Kato, Masatomo. 2023. Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells. In PloS one, 18, e0280331. doi:10.1371/journal.pone.0280331. https://pubmed.ncbi.nlm.nih.gov/36630412/

5. Rodríguez Cruz, Pedro M, Cossins, Judith, Estephan, Eduardo de Paula, Palace, Jacqueline, Beeson, David. . The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. In Brain : a journal of neurology, 142, 1547-1560. doi:10.1093/brain/awz107. https://pubmed.ncbi.nlm.nih.gov/31081514/